Study of flow effects on temperature-controlled radio-frequency ablation using phantom experiments and forward simulations

Purpose Blood perfusion is known to add variability to hepatic radiofrequency ablation (RFA) treatment outcomes. Simulation-assisted treatment planning taking into account blood perfusion may solve this problem in the future. Hence, this study aims to study perfusion effects on RFA in a controlled environment and to compare the outcome to a prediction made using finite volume simulations. Methods Ablation zones were induced in tissue-mimicking, thermochromic ablation phantoms with a single flow channel, using a RF generator with needle temperature controlled power delivery and a monopolar needle electrode. Channel radius and saline flow rate were varied and the impact of saline flow on the ablated cross-sectional area, on a potential occurrence of directional effects as well as on the delivered generator power input was studied. Finite-volume simulations reproducing the experimental geometry, flow conditions and generator power input were conducted in a second step and compared to the experimental ablation outcomes. Results Vessels of different radii affected the ablation result in different manners. For the channel radius of 0.275 mm both the ablated area and energy input reduced with increasing flow rate. For radius 0.9 mm the ablated area reduced with increasing flow rate but the energy input increased. An increasing area and energy input were observed towards larger flow rates for the channel radius of 2.3 mm. Directional effects, i.e., shrinking of the lesion upstream of the needle and an extension thereof downstream, were observed only for the smallest channel radius. The simulations qualitatively confirmed these observations. When using the simulations to make a prediction of ablation outcomes with flow, the mean absolute error between experimental and predicted ablation outcomes was reduced from 23% to 12% as compared to neglecting flow effects. Conclusion Simulations can improve the prediction of RFA ablation regions in the presence of various blood flow effects. Our findings therefore underline the potential of simulation-assisted, patient-individual RFA treatment planning and guidance for the prediction of RFA outcomes in the presence of blood flow. Additional comments ### Competing Interest Statement Marco Baragona, Valentina Lavezzo, Aaldert Elevelt and Ralph Maessen are currently employed by Philips Research Europe. Volkmar Schulz is a CEO of Hyperion Hybrid Imaging Systems GmbH.